IOBT stock

IO Biotech Inc (IOBT) financials · $98.2M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

IO Biotech Inc (IOBT) $98.2M cap.

Cached annual income statement
LineFY2024FY2023
Operating Income-$95.2M-$91.4M
Net Income-$95.5M-$86.1M
Cached annual balance sheet
LineFY2024FY2023
Total Assets$67.7M$150.7M
Current Assets$65.0M$147.3M
Cash & Equivalents$60.0M$143.2M
PP&E$638.0K$847.0K
Total Liabilities$20.7M$17.6M
Current Liabilities$19.5M$15.7M
Short-term DebtN/AN/A
Long-term DebtN/AN/A
Shareholders' Equity$47.0M$133.2M
Retained Earnings-$359.3M-$263.8M
Cached annual cash flow
LineFY2024FY2023
Operating Cash Flow-$82.3M-$71.7M
CapEx$44.0K$323.0K
Investing Cash Flow-$44.0K-$323.0K
Financing Cash FlowN/A$71.9M
Free Cash Flow-$82.4M-$72.1M
These statements as JSON? API free 100/day

FAQ

What is IOBT P/E and revenue?

IO Biotech Inc (IOBT) $98.2M cap.

What is IOBT revenue?

IOBT income-statement cache has no revenue figure yet.

Is IOBT profitable?

IO Biotech Inc last cached net income is -$95.5M (FY2024).

What are IOBT total assets?

IO Biotech Inc last cached total assets are $67.7M (FY2024).

What is IOBT free cash flow?

IO Biotech Inc last cached free cash flow is -$82.4M (FY2024).

Not investment advice. Cached statements, not a live tape.